IN VIVO’s Deals Of The Month: June 2016
IN VIVO’s editors pick June’s most significant deals, including Novartis and Xencor’s IO deal and big money for a synthetic bio start-up. (Article free with registration.)
You may also be interested in...
The world's second-largest orthopedic device firm, Zimmer Biomet, is making its biggest move since Zimmer and Biomet merged in 2015 with a $1bn acquisition of spine-device specialists LDR.
In Vivo's editors pick January's most significant deals, including Roche's acquisition of Flatiron and Moderna's latest big private fundraising. (Free article.)
In Vivo's editors pick January's most significant deals, including an alliance of players new to health care and Celgene's big buys. (Free article.)